| Wed, Jul 8, 2009 | | • | FDA Calendar Updates: King Pharma, Pain Therapeutics
at Seeking Alpha (Wed, Jul 8)
| | Tue, Jul 7, 2009 | | • | Lawson Software, Spectrum Pharmaceuticals and China Housing & Land Development lead small-cap volume in pre-market
SmallCapInvestor.com (Tue, Jul 7)
| | • | ALLOS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Jul 7)
| | • | Allos Therapeutics Completes Enrollment in Randomized Phase 2b Trial of Pralatrexate in Patients with Advanced Non-Small Cell Lung Cancer
Business Wire (Tue, Jul 7)
| | Fri, Jun 26, 2009 | | • | ALLOS THERAPEUTICS INC Files SEC form 8-K/A, Change in Directors or Principal Officers
EDGAR Online (Fri, Jun 26)
| | Fri, Jun 19, 2009 | | • | The Next Million-Dollar Penny Stock
at Motley Fool (Fri, Jun 19)
| | Tue, Jun 16, 2009 | | • | Dows biggest loss in 2 months; Evergreen Energy leads Colorado gainers
at bizjournals.com (Tue, Jun 16)
| | Fri, Jun 12, 2009 | | • | ALLOS THERAPEUTICS INC Files SEC form 8-K, Other Events
EDGAR Online (Fri, Jun 12)
| | Thu, Jun 11, 2009 | | • | Four Hot Biotech Stocks to Buy: Analyst
at CNBC (Thu, Jun 11)
| | Wed, Jun 10, 2009 | | • | Wednesday's Options Recap
at Seeking Alpha (Wed, Jun 10)
| | Tue, Jun 9, 2009 | | • | Tuesday Options Update: GLD, LEA, ALTH, MS, FXI, XHB, EEM, BNI
at Seeking Alpha (Tue, Jun 9)
| | Wed, Jun 3, 2009 | | • | Biotech Calendar: Key FDA Action Dates
at TheStreet.com (Wed, Jun 3)
| | • | Allos Therapeutics to Present at the 8th Annual Needham Life Sciences Conference
Business Wire (Wed, Jun 3)
| | Tue, Jun 2, 2009 | | • | Dow jumps to start June; General Moly leads Colorado gainers
at bizjournals.com (Tue, Jun 2)
| | Mon, Jun 1, 2009 | | • | ALLOS THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Mon, Jun 1)
| | • | FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
at Seeking Alpha (Mon, Jun 1)
| | Sat, May 30, 2009 | | • | Allos Therapeutics Reports Updated Data from Pivotol Phase 2 PROPEL Study of Pralatrexate at 45th ASCO Annual Meeting
Business Wire (Sat, May 30)
| | • | Allos: 15-Month Median Survival in PTCL Study
at TheStreet.com (Sat, May 30)
| | Tue, May 26, 2009 | | • | AgFeed Industries, Canadian Solar and Allos Therapeutics lead small-cap volume in pre-market
SmallCapInvestor.com (Tue, May 26)
| | • | ALLOS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, May 26)
|
Add ALTH News to My Yahoo!:
 
| |
|
0.45% Nasdaq 
0.20%
Headlines
